242 related articles for article (PubMed ID: 27330105)
21. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
[TBL] [Abstract][Full Text] [Related]
22. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
23. New insights into the biology of renal cell carcinoma.
Li L; Kaelin WG
Hematol Oncol Clin North Am; 2011 Aug; 25(4):667-86. PubMed ID: 21763962
[TBL] [Abstract][Full Text] [Related]
24. Morphologic and molecular characterization of renal cell carcinoma in children and young adults.
Bruder E; Passera O; Harms D; Leuschner I; Ladanyi M; Argani P; Eble JN; Struckmann K; Schraml P; Moch H
Am J Surg Pathol; 2004 Sep; 28(9):1117-32. PubMed ID: 15316311
[TBL] [Abstract][Full Text] [Related]
25. Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p.
Füzesi L; Gunawan B; Bergmann F; Tack S; Braun S; Jakse G
Histopathology; 1999 Aug; 35(2):157-61. PubMed ID: 10460661
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
Nagy A; Buzogany I; Kovacs G
Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
[TBL] [Abstract][Full Text] [Related]
27. Clear Cell Papillary Renal Cell Carcinoma.
Zhao J; Eyzaguirre E
Arch Pathol Lab Med; 2019 Sep; 143(9):1154-1158. PubMed ID: 30672334
[TBL] [Abstract][Full Text] [Related]
28. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
29. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
30. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
31. Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.
Rowsell C; Fleshner N; Marrano P; Squire J; Evans A
J Clin Pathol; 2007 Apr; 60(4):426-8. PubMed ID: 17405978
[TBL] [Abstract][Full Text] [Related]
32. A Differential Transcriptional Regulome Approach to Unpack Cancer Biology: Insights on Renal Cell Carcinoma Subtypes.
Caliskan A; Arga KY
OMICS; 2023 Nov; 27(11):536-545. PubMed ID: 37943533
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
Pan CC; Chen PC; Chiang H
Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
[TBL] [Abstract][Full Text] [Related]
34. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
[TBL] [Abstract][Full Text] [Related]
35. High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.
Kouba EJ; Eble JN; Simper N; Grignon DJ; Wang M; Zhang S; Wang L; Martignoni G; Williamson SR; Brunelli M; Luchini C; Calió A; Cheng L
Mod Pathol; 2016 Nov; 29(11):1347-1357. PubMed ID: 27469331
[TBL] [Abstract][Full Text] [Related]
36. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
37. BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma.
Shinmura K; Igarashi H; Kato H; Koda K; Ogawa H; Takahashi S; Otsuki Y; Yoneda T; Kawanishi Y; Funai K; Takayama T; Ozono S; Sugimura H
Medicine (Baltimore); 2015 Jun; 94(24):e989. PubMed ID: 26091477
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
[TBL] [Abstract][Full Text] [Related]
39. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
40. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
